Max Schultheiß

Max Schultheiß has a diverse work experience that spans across different companies and roles. Max started their career in 2010 as a Sozialversicherungsfachangestellter at AOK Bayern, where they worked until July 2012. In 2012, they interned at Rhön Klinikum AG, gaining experience in patient administration for a month. From 2016 to 2017, Max completed an internship in government affairs and health policy at GlaxoSmithKline Pharma GmbH. Max then continued at GlaxoSmithKline Pharma GmbH in 2017 as a Masterand in government affairs and health policy until February 2018. Max moved to the Healthcare Business of Merck in 2018, where they had multiple roles in pricing and reimbursement. Max started as a Junior Manager in March 2018 and became a Manager in December 2019. From December 2021 to December 2022, Max worked as a Senior Manager in pricing and reimbursement at the same company. Currently, they hold the position of Senior Manager in pricing and reimbursement at Stemline Therapeutics, starting in January 2023.

Max Schultheiß completed their education at the University of Bayreuth from 2012 to 2018. During this time, they pursued a combined B.Sc. and M.Sc. degree in health economics.